About Vardhman Chemtech Limited
Data last updated: 06 January 2026
Vardhman Chemtech Limited is a public limited company based in Chandigarh, Chandigarh, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 21 August 1996, the company has been in operation for over 30 years.
Registered with ROC Chandigarh under CIN U24117CH1996PLC018656.
Capital: an authorised share capital of ₹100 Cr and a paid-up capital of ₹10 Lakh. Formerly known as Vardhman Chemtech Private Limited. It is led by directors including Devang Manharlal Ajmera and Piyush Manharlal Ajmera.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Sco 85 Sector 35 C, Chandigarh, Chandigarh, India – 160036.
As per the financials filed for FY 2025, the company reported a revenue of ₹208.69 Cr, a decline of 13% compared to the previous year.
The company has a workforce of approximately 181 employees as per the latest available data.
The company is associated with 2 brands - Dpb Group, Vardhman Chemtech. As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹869.07 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vardhmanchemtech.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressSco 85 Sector 35 C, Chandigarh, Chandigarh, India – 160036
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Vardhman Chemtech Limited
Vardhman Chemtech Limited has one previous CIN (Corporate Identification Number): L24117CH1996PLC018656. The current CIN is U24117CH1996PLC018656, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24117CH1996PLC018656 | Current |
| L24117CH1996PLC018656 | Previous |
Associated Brands with Vardhman Chemtech Limited
Vardhman Chemtech Limited operates two associated brands: DPB Group and Vardhman Chemtech. These brands represent Vardhman Chemtech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| DPB Group is engaged in manufacturing pharmaceutical APIs in India. | dpbpharma.com | |
| Manufacturer of bulk drugs, intermediates and fine chemicals | vardhmanchemtech.com |
Competitors & Alternatives of Vardhman Chemtech Limited
Brands and companies operating in the same space as Vardhman Chemtech Limited include Laurus Labs, Symbiotec, WuXi AppTec and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
WuXi AppTec
|
Provider of CRO and CDMO services | Shanghai, China, China | 2000 |
ANI Pharmaceuticals
|
Branded and generic prescription drugs are developed, manufactured, and marketed. | Baudette, United States, United States | 1996 |
Aptar
|
Regulatory support, brand differentiation, and prototyping services are provided. | Crystal Lake, United States, United States | 1992 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
CHEPLAPHARM
|
Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany, Germany | 1998 |
Red Nucleus
|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | Yardley, United States, United States | 2014 |
Ipsen
|
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 1929 |
Eurofins Scientific
|
Laboratory testing and contract research services are provided globally. | Luxembourg, Luxembourg, Luxembourg | 1987 |
Business Activity of Vardhman Chemtech Limited
Vardhman Chemtech Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Vardhman Chemtech Limited
Vardhman Chemtech Limited is audited by Simrit & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Simrit & Associates | blur-value | blur-value | blur-value |
Board of Directors of Vardhman Chemtech Limited
Vardhman Chemtech Limited is currently managed by 4 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Devang Manharlal Ajmera
Also directs:
Kinvan Private Limited, Vardhman Chemtech Limited, Dpb Pharmaceuticals Limited and 1 more
|
Director | 02 Feb 2021 | 5 Years 5 Months | Current |
| Piyush Manharlal Ajmera | Director | 02 Feb 2021 | 5 Years 5 Months | Current |
| Bhavin Manharlal Ajmera | Director | 02 Feb 2021 | 5 Years 5 Months | Current |
|
Sharvan Bhatt
Also directs:
Vardhman Chemtech Limited, Dpb Antibiotics Private Limited, Sbn Pharma Tech Llp and 1 more
|
Whole-Time Director | 21 Jul 2021 | 4 Years 11 Months | Current |
Financials of Vardhman Chemtech Limited FY 2024 filings available
Vardhman Chemtech Limited reported revenue of ₹208.69 Cr (down 13% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Vardhman Chemtech Limited
As of FY 2023, Vardhman Chemtech Limited's shareholding pattern shows 0.50% by promoters, 99.50% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Vardhman Chemtech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2022 | Hdfc Bank Limited | ₹25 Cr | Open |
| 04 Aug 2022 | Hdfc Bank Limited | ₹62 Cr | Satisfied |
| 20 Aug 2014 | Punjab Reliable Investments Private Limited | ₹73 Lakh | Satisfied |
| 24 May 2014 | State Bank of Patiala | ₹268.38 Cr | Satisfied |
| 29 Mar 2013 | Punjab Kashmir Finance Limited | ₹1.5 Cr | Satisfied |
Total charge records: 24 View all charges
Employees and EPFO Compliance at Vardhman Chemtech Limited
Vardhman Chemtech Limited has a workforce of 181 employees as of Sep 11, 2024.
Employee Count & EPFO Data of Vardhman Chemtech Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Vardhman Chemtech Limited
GSTIN & GST Filing Data of Vardhman Chemtech Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Vardhman Chemtech Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Vardhman Chemtech Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Vardhman Chemtech Limited
MSME Payment Delays by Vardhman Chemtech Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Vardhman Chemtech Limited
Subsidiaries & Group Companies of Vardhman Chemtech Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vardhman Chemtech Limited with ownership details.
MCA Filings & Documents of Vardhman Chemtech Limited
MCA Filings & Documents of Vardhman Chemtech Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Vardhman Chemtech Limited
Frequently Asked Questions about Vardhman Chemtech Limited
Vardhman Chemtech Limited is an active public limited company in the pharma sector based in Chandigarh, Chandigarh, India. It was incorporated on 21 August 1996 (30+ years old) and is registered under CIN U24117CH1996PLC018656. The company has 181 employees.
Vardhman Chemtech Limited reported revenue of ₹208.69 Cr for FY 2025 (down 13.00% YoY).
The current directors of Vardhman Chemtech Limited are:
The primary industry of Vardhman Chemtech Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Vardhman Chemtech Limited can be reached at the registered office: Sco 85 Sector 35 C, Chandigarh, Chandigarh, India – 160036, or through the website vardhmanchemtech.com.
The authorised capital is ₹100 Cr, and the paid-up capital is ₹10 Lakh.